Highlights
KLSE: YSPSAH (7178)       Y.S.P. SOUTHEAST ASIA HOLDING BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
2.74   -0.01 (0.36%)  2.74 - 2.75  12,800
Analyze this stock with MQ Trader system

Additional Listing

Hints :
[1] Click the View Entitlement icon table to view the Additional Listing detail page.

Click here to modify the Visible Columns.

Ann. Date Date Type Units Price Total NOSH View
08-Aug-2011 09-Aug-2011 Rights Issue 33,260,144 1.000 133,042,985 Additional Listing Detail
21-May-2015 22-May-2015 ESOS 204,000 1.490 133,246,985 Additional Listing Detail
04-Jun-2015 05-Jun-2015 ESOS 448,000 1.490 133,694,985 Additional Listing Detail
19-Jun-2015 22-Jun-2015 ESOS 229,000 1.490 133,923,985 Additional Listing Detail
08-Jul-2015 09-Jul-2015 ESOS 325,000 1.490 325,000 Additional Listing Detail
16-Jul-2015 20-Jul-2015 ESOS 158,000 1.490 134,406,985 Additional Listing Detail
10-Aug-2015 11-Aug-2015 ESOS 82,000 1.490 134,488,985 Additional Listing Detail
21-Aug-2015 24-Aug-2015 ESOS 26,000 1.490 134,514,985 Additional Listing Detail
13-Oct-2015 15-Oct-2015 ESOS 3,000 1.490 134,517,985 Additional Listing Detail
05-Nov-2015 06-Nov-2015 ESOS 5,000 1.490 134,522,985 Additional Listing Detail
01-Dec-2015 02-Dec-2015 ESOS 77,000 1.490 134,599,985 Additional Listing Detail
13-Jan-2016 14-Jan-2016 ESOS 5,000 1.490 134,604,985 Additional Listing Detail
29-Jan-2016 02-Feb-2016 ESOS 12,000 1.490 134,616,985 Additional Listing Detail
24-May-2016 25-May-2016 ESOS 8,000 1.490 134,624,985 Additional Listing Detail
27-Jun-2016 28-Jun-2016 ESOS 29,000 1.490 134,653,985 Additional Listing Detail
09-Aug-2016 10-Aug-2016 ESOS 3,000 1.490 134,656,985 Additional Listing Detail
15-Nov-2016 16-Nov-2016 ESOS 5,000 1.890 134,661,985 Additional Listing Detail
25-Nov-2016 28-Nov-2016 ESOS 5,000 1.890 134,667,985 Additional Listing Detail
23-Feb-2017 24-Feb-2017 ESOS 18,000 1.890 134,685,985 Additional Listing Detail
10-Apr-2017 11-Apr-2017 ESOS 36,000 1.890 134,721,985 Additional Listing Detail
14-Apr-2017 17-Apr-2017 ESOS 47,000 1.890 134,768,985 Additional Listing Detail
27-Apr-2017 28-Apr-2017 ESOS 40,000 1.890 134,811,985 Additional Listing Detail
09-May-2017 11-May-2017 ESOS 46,000 1.890 134,857,985 Additional Listing Detail
22-May-2017 23-May-2017 ESOS 187,000 1.890 135,047,985 Additional Listing Detail
08-Jun-2017 09-Jun-2017 ESOS 76,000 1.890 135,134,985 Additional Listing Detail
15-Jun-2017 16-Jun-2017 ESOS 1,067,000 1.890 136,201,985 Additional Listing Detail
22-Jun-2017 23-Jun-2017 ESOS 210,000 1.890 136,411,985 Additional Listing Detail
23-Jun-2017 28-Jun-2017 ESOS 37,000 1.890 136,468,985 Additional Listing Detail
10-Jul-2017 11-Jul-2017 ESOS 65,000 1.890 136,533,985 Additional Listing Detail
01-Aug-2017 02-Aug-2017 ESOS 102,000 1.890 136,640,985 Additional Listing Detail
14-Aug-2017 15-Aug-2017 ESOS 22,000 1.890 136,662,985 Additional Listing Detail
24-Aug-2017 25-Aug-2017 ESOS 21,000 1.890 136,691,985 Additional Listing Detail
21-Sep-2017 25-Sep-2017 ESOS 20,000 1.890 136,711,985 Additional Listing Detail
20-Oct-2017 23-Oct-2017 ESOS 33,000 1.890 136,744,985 Additional Listing Detail
28-Nov-2017 29-Nov-2017 ESOS 2,000 1.890 136,746,985 Additional Listing Detail
18-Jan-2018 19-Jan-2018 ESOS 10,000 1.890 136,761,985 Additional Listing Detail
09-Feb-2018 12-Feb-2018 ESOS 10,000 1.890 136,771,985 Additional Listing Detail
19-Mar-2018 20-Mar-2018 ESOS 113,000 2.400 137,047,985 Additional Listing Detail
04-Apr-2018 05-Apr-2018 ESOS 3,000 2.400 137,123,985 Additional Listing Detail
24-Apr-2018 25-Apr-2018 ESOS 5,000 2.400 137,131,985 Additional Listing Detail
07-May-2018 08-May-2018 ESOS 62,000 1.890 137,193,985 Additional Listing Detail
14-May-2018 15-May-2018 ESOS 270,000 2.400 137,463,985 Additional Listing Detail
05-Jun-2018 06-Jun-2018 ESOS 442,000 2.400 137,944,985 Additional Listing Detail
26-Jun-2018 27-Jun-2018 ESOS 33,000 1.890 137,977,985 Additional Listing Detail
24-Jul-2018 25-Jul-2018 ESOS 8,000 1.890 137,985,985 Additional Listing Detail
14-Aug-2018 15-Aug-2018 ESOS 5,000 2.400 138,023,985 Additional Listing Detail
23-Aug-2018 24-Aug-2018 ESOS 27,000 2.400 138,050,985 Additional Listing Detail
05-Sep-2018 06-Sep-2018 ESOS 34,000 2.400 138,139,985 Additional Listing Detail
25-Sep-2018 26-Sep-2018 ESOS 22,000 2.400 138,220,985 Additional Listing Detail
05-Oct-2018 08-Oct-2018 ESOS 10,000 2.400 138,250,985 Additional Listing Detail
18-Oct-2018 19-Oct-2018 ESOS 14,000 1.890 138,264,985 Additional Listing Detail
08-Nov-2018 09-Nov-2018 ESOS 10,000 1.490 138,274,985 Additional Listing Detail
23-Nov-2018 26-Nov-2018 ESOS 3,000 2.400 138,288,985 Additional Listing Detail
07-Dec-2018 10-Dec-2018 ESOS 3,000 2.400 138,296,985 Additional Listing Detail
21-Dec-2018 24-Dec-2018 ESOS 5,000 1.490 138,301,985 Additional Listing Detail
08-Jan-2019 09-Jan-2019 ESOS 7,000 2.400 138,312,985 Additional Listing Detail
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.

  4 people like this.
 
shpg22 1st half topline & bottomline both increased. Expect 3rd quarter bottomline to increase strongly (80-100% YoY). ACCUMULATE at fair price 3.25.
29/08/2017 19:23
skyea Ysp earnings is seasonal so qoq comparison is not meaningful. Yoy is the only way
29/08/2017 20:44
skyea Trailing 4 qtr earnings makes 2.87 share price 14.1 PE. Any knee jerk reaction to the bottom is going to give you 13 PE pharma company with highest margin, roe and roa
29/08/2017 20:50
skyea comparing Q2 for 2014, 2015, 2016, 2017, this quarter is very good. on par with last year. Q2 17= Q2 16, which is > Q2 15 and Q2 14
29/08/2017 22:50
Flintstones Investors should know now never extrapolate one quarter of good results
30/08/2017 10:14
shpg22 Overeaction by just 1 quarter. 1st half YoY revenue & profit still growing.
30/08/2017 10:39
necro fuhhh sell d @RM3.05 coz know that 2nd quarter is always the weakest quarter YoY..hopefully market correct more to level where can buy @ cheap price
30/08/2017 14:56
yansheng2213 clever =)
30/08/2017 18:04
shpg22 Time d market is a fools game...heard before
30/08/2017 20:05
gongkia i didnt check the price :P
31/08/2017 02:15
necro waaa down cheaper!!
05/09/2017 11:55
necro support broke!!gg.com liaooooo!!! horeyyyy!!
05/09/2017 11:55
gcke Seemed like the consolidation phase has been over after the big drop in the stock price on the release of the 2QR.
2.Today trend and move momentum for the price seemed to be positive.
3.Hopefully the support momentum can be sustained for the price to gradually move up.
4.The coming 3Qr should be better to support the price at the previous closing high or higher as what the analyst has written and expected.

Hope for better days.Always stay positive:-)))
19/09/2017 19:47
Evolution4 what internal news u know espesp?
27/09/2017 23:26
SYZZ anyone knws what is the doorgift for the AGM?
02/10/2017 11:17
gcke @SYZZ is the token gift of appreciation given out to all eligible shareholders or their proxies,nominees who register and attend the company AGM.
2.Can be in the form of KFC,White-town Coffee vouchers.Aji-No-Moto for example will issued out to all attendees the company products.The amount and quantities given out are in the value ranging from RM 30- RM 200.
3.Air Asia will give out free air travel ticket overseas.
4.Try attending on of such AGM to gather some good experience.In addition some companies like ICON,Astro,Air Asia,etc provide morning breakfast.Others like Malakoff also provide lunch pack.

Hope that explained.Smart investing:-)))
03/10/2017 13:43
FKLI13 What happen to YSP ? Keep on eating !
11/10/2017 16:33
michaelgoh Flying high, company doing well can buy
11/10/2017 16:39
kakashit The privatisation price of Hovid is at 38cents, 1.5 times of the net asset per share.

Ngam ngam YSP is also selling at 1.5 p/naps, given YSP has neglectable intangible asset, no dilution from warrants and also no record of manufacutring license revocation,

that's mean the real instrinsic value of YSP should fare better than Hovid.
12/10/2017 14:18
Anson Ang Qr must b bad.. Ppl throw
16/11/2017 16:48
Thkent91 Masuk Holland. Looks like all pharmaceutical company not doing any well. Long term RM 6
16/11/2017 19:49
Angel of KLSE 大马股仙 result not bad, why go hol land kan?
20/11/2017 13:21
kakashit Yes, share price might go to Holland, but the dividend will only go to ur bank acc
12/02/2018 10:35
Bitter Chocolate Super under value share, this company profile tell it worth more than u can imagine and the payout will come very soon. I stake all in..The history of this company tell May of each year is the best time to grab...Deviden + Share price soar all happening soon.
14/05/2018 12:09
PrincsX anyonw knw what is YSPSAH AGM doorgift for year 2017??? this year AGM location a bit far...
24/05/2018 12:41
k3nthiew https://www.thestar.com.my/business/business-news/2018/07/18/cimb-research-positive-on-ysp-southeast-asia-tp-rm3pt46/


CIMB also ask to buy now. More contracts from MoH won.
19/07/2018 09:58
thesteward Didn’t CIMB just up the tp to rm4 today?
14/08/2018 17:54
thesteward Really undervalue
14/08/2018 17:55
k3nthiew https://www.malaymail.com/s/1664223/health-protection-scheme-for-b40-group-for-implementation-next-year-says-dz

Health insurance scheme will expanded to Middle 40 too... Hope Ysp can get more market share...
21/08/2018 08:56
Jasper Coo Good time to accumulate more and gain more profit :)
21/08/2018 11:20
TANCHEECHIM (File pix) Photo shows a man getting a health check from a medical personnel. The Health Ministry is targeting the end of the year to introduce a free medical coverage plan for those in the bottom 40 (B40) economic category. Archive image for illustration purposes only. Pix courtesy of UNIMAP

By AUDREY VIJAINDREN - August 10, 2018 @ 12:33pm

KUALA LUMPUR: The Health Ministry is targeting the end of the year to introduce a free medical coverage plan for those in the bottom 40 (B40) economic category.
Of the only 30 per cent of Malaysians with some form of medical health insurance, 15 per cent purchased their own medical plan, while between 10 and 15 per cent are covered by their employers.
“Sooner or later, we will have to implement some sort of social health insurance for all Malaysians, but we will start with the B40 group.
“If we are able to cover the bottom 40 per cent, a large proportion of the population will at least have some form of health coverage. Once that is done, we can look into universal coverage for all Malaysians.
“However, we have to work out the details about where the money is going to come from. One of the models proposed is very minimal coverage – for example, RM10,000, so the premiums are low enough to sustain.
“Eventually, we will have to discuss this matter with all stakeholders before we firm up a proposal,” said Deputy Minister of Health Dr Lee Boon Chye.
He said this at after opening the Excellence in Breast Cancer Therapy and Support Conference in Nexus Bangsar South here, today.
Also present at the three-day conference was Pink Ribbon Wellness (L) Foundation founder and chairman, Datuk Dr Devanand; and Beacon Hospital medical director and consultant clinical oncologist, Datuk Dr Mohamed Ibrahim Wahid.
The cost of medical treatment is Malaysia is becoming a burden thanks to inflation of between 10 and 15 per cent annually, which is due to the country’s ageing population, the availability of new treatments and technologies which are expensive, and higher expectations of the efficacy of medical treatment by the community.
“At the end of the day, the Health Ministry will have to look at the cost effectiveness of treatments and try our very best to bring down the price.


#######
“We have successfully reduced the price of Hepatitis C therapy from RM128,000 to below RM1,500 by using generic drugs. We had a strong argument because it is a contagious disease, so we could use that argument to ‘arm-twist’ the multi-national drug companies.

“It’s more difficult with the treatment of cancer, but at the end of the day, if we are unable to reduce the cost, we will have to look at using more generic drugs as an alternative,” Dr Lee added.
#########



The conference is highlighting alarming statistics, including that one in 19 women will develop breast cancer in their lifetime; and that breast cancer is the leading cause of cancer deaths in women under the age of 40.
30/08/2018 11:20
Thkent91 Slow and steady. See you at rm6 in another 4 years time
22/09/2018 00:14
trulyinvest bought 3.24
24/09/2018 10:55
trulyinvest sold 3.28 thx
25/09/2018 09:17
eriktime 3.50 very soon
01/10/2018 18:28
moven00 Hopeful the coming quarter result will be favorable and more contribution to come from Vietnam and Indonesia biz
17/10/2018 08:19
Davidl Hey guys, I join de boat today! Cheers!
21/11/2018 13:22
trulyinvest i oso joined. 2.98
21/11/2018 13:51
Davidl Qtr result good! Time for empire strikes back!
21/11/2018 18:09
moven00 Good...good...
21/11/2018 19:38
trulyinvest So so only I think
21/11/2018 19:43
Davidl The group is cautiously optimistic of maintaining the financial performance toward the end of the year.
22/11/2018 00:06
wwwcomment Is good to accumulate.
22/11/2018 10:32
Davidl AHIB: We continue to like YSP for its bargain valuations against the backdrop of the coming favourable healthcare policy, which we think could benefit generic drug producers such as YSP. Higher export-oriented exposure (38% of total revenue by 2020E), underpinning YSP’s prospects for the foreseeable future, is a boon as well!
23/11/2018 12:58
tanweijen Hi, besides due to market sentiment nowadays, does anyone know why this counter has dropped >10% since the latest quarter released although the result was not that bad? based on the past 2 years history, Q4 will have better results. Thus, it has high chances its revenue and net profit to achieve new high after total up the Q1-Q3 2018. I'm newbie here to learn
15/12/2018 13:26
UnicornP First of all, prospect isn't convincing at all.
1) "With unabated challenges in both the domestic and international fronts that impacted the business, the group will place greater emphasis on enhancing operational efficiency, increasing product registration, effective and bolder marketing, promotional and sales strategies."
--> This means the group finds it hard to get more biz so now turn to miscellaneous measures to gain something. No huge growth.

2) "The group is cautiously optimistic of maintaining the financial performance toward the end of the year."
--> The group just dares to say maintaining the results, not like they are confident to achieve a better performance. No earnings surprise.

You gotta find a company which starts to turnaround or have huge growth coming near.
15/12/2018 13:43
tanweijen Thank you UnicornP for your kind opinions. Appreciate
15/12/2018 19:07
Albukhary Unicorn, sometime it depends on the integrity of the management as well . certain management said very optimistic to achieved satisfactory financial performance, end up having huge losses in the next quarter.
15/12/2018 19:38
RainT seem a good counter for invest
25/12/2018 14:26
Veron_teo wait 1.5
25/12/2018 14:55


 

402  326  492  672 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ARMADA 0.22+0.06 
 SAPNRG 0.285-0.005 
 SUMATEC 0.005-0.01 
 MYEG 1.01-0.06 
 BARAKAH 0.08+0.02 
 NEXGRAM 0.020.00 
 IRIS 0.15+0.005 
 XINGHE 0.045+0.005 
 KNM 0.09+0.01 
 ECONBHD 0.515+0.045 

TOP ARTICLES

1. Fear on Bumi Armada is probably overdone - felicity Good Articles to Share
2. 当遇上基本面投资法(上) “反向”战略非唱反调/冷眼 【冷眼专栏】漫漫投资路
3. [转贴]《东方华尔街》告诉你,炒家如何炒高一只股 Good Articles to Share
4. THE PERCEPTION OF P/E or: How I learned to fear my Wife the bursa journey that worked for me. 2000-2019
5. Stocks on Radar - Elsoft Research (0090) AmInvest Research Reports
6. Is QL Resources worth investing now? kcchongnz kcchongnz blog
7. FPI FY19 revenue growth expected to hit 15% FPI 2大因素前景看好台灣聯友今年再 尋突破
8. Evening Market Summary - 17 Jan 2019 KLSE Traders Update and Ideas
Partners & Brokers